Jim Wallace is the founder of DecisionRx. DecisionRx has raised $100M in total funding. Backed by The Carlyle Group. Based in Indianapolis, United States.
Jim Wallace is the former CEO of DecisionRx, a company focused on enhancing medication efficacy through pharmacogenomics. He is also the author of "Precision Medicine: AI and the Science of Personalized Healthcare," a book that explores transforming medicine with wearable tech, genomics, Big Data, and AI. Wallace holds an MBA from Harvard and a Doctor of Business Administration from the University of South Florida. His background includes a role as a senior researcher at Harvard Business School and experience at SpaceX.
Full founder directory · Investor directory · Company funding database · Fundraising library